Results 81 to 90 of about 2,327,467 (213)
High blood pressure, blood glucose, serum cholesterol, and BMI are risk factors for cardiovascular diseases and some of these factors also increase the risk of chronic kidney disease and diabetes.
Castetbon, Katia +1 more
core +1 more source
MicroRNAs in Cardiometabolic Diseases
BACKGROUND: MicroRNAs (miRNAs) are ~22-nucleotide noncoding RNAs with critical functions in multiple physiological and pathological processes. An explosion of reports on the discovery and characterization of different miRNA species and their involvement in almost every aspect of cardiac biology and diseases has established an exciting new dimension in ...
Anna Meiliana, Andi Wijaya
openaire +3 more sources
The Role of Epigenetic Modifications in Cardiometabolic Diseases
The risk of cardiometabolic disease such as type II diabetes and cardiovascular disease (CVD) increases with age. Both of these diseases are important determinants of overall health and longevity.
Taulant Muka +14 more
core +1 more source
Genetics of cardiometabolic disease progression
Abstract Background Genome-wide association studies have been crucial in gaining insights into the genetics of cardiometabolic diseases. However, little is known about the genetics of cardiometabolic disease progression which may have both a different genetic architecture and significant implications
Johanne M. Justesen +7 more
openaire +2 more sources
Background Cardiometabolic health has been worsening among young adults, but the prevalence of lifestyle risk factors and cardiometabolic diseases is unclear.
Victor W. Zhong +4 more
core +1 more source
Gene-exercise interactions in the development of cardiometabolic diseases
Cardiometabolic diseases such as type 2 diabetes mellitus, stroke, and coronary heart disease are complex disorders influenced by multiple genetic and environmental factors.
Kumpei Tanisawa +2 more
doaj +1 more source
Background Diabetes mellitus, particularly type 2 diabetes, is a growing health concern in low- and middle-income countries (LMICs). The potential impact of newer diabetes medications, such as glucagon-like peptide 1 (GLP-1) receptor agonists and sodium ...
Global Health & Population Project on Access to Care for Cardiometabolic Diseases (HPACC) +1 more
core +1 more source
Developmental origins of cardiometabolic diseases: The role of the maternal diet.
Developmental origins of cardiometabolic diseases have been related to maternal nutritional conditions. In this context, the rising incidence of arterial hypertension, diabetes type II and dyslipidemia has been attributed to genetic programming. Besides,
Aiany C. Simões-Alves +5 more
core +1 more source
Insight into the pathophysiology of cardiometabolic diseases using multiple omics approaches [PDF]
Cardiometabolic diseases cover a wide spectrum of conditions, including insulin resistance, metabolic syndrome and prediabetes, and clinical conditions such as type 2 diabetes mellitus and cardiovascular diseases.
Wang, W.
core

